author-photo

Karin Hardt

GlaxoSmithKline

39

Papers

4038

Citations

Citation Trend

Filter By

Papers (24) Sort By

Journal Conference Others

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.

2021 The New England Journal of Medicine
Show All
- Source
- Cite
- Save
Citations (468)
Vaccine strategies: Optimising outcomes

2016 Vaccine
Show All
- Source
- Cite
- Save
Citations (0)
Vaccine strategies: Optimising outcomes

2016 Vaccine
Show All
- Source
- Cite
- Save
Citations (44)
Primary and booster vaccination with an inactivated poliovirus vaccine (IPV) is immunogenic and well-tolerated in infants and toddlers in China

2016 Vaccine
Show All
- Source
- Cite
- Save
Citations (7)
Lasting immune memory against hepatitis B following challenge 10-11 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 and 11-12 months of age.

2015 Vaccine
Show All
- Source
- Cite
- Save
Citations (25)
Evaluation of a new syringe presentation of reduced-antigen content diphtheria, tetanus, and acellular pertussis vaccine in healthy adolescents - A single blind randomized trial

2015 Human Vaccines & Immunotherapeutics
Show All
- Source
- Cite
- Save
Citations (0)
Immunogenicity and reactogenicity of a decennial booster dose of a combined reduced-antigen-content diphtheria–tetanus–acellular pertussis and inactivated poliovirus booster vaccine (dTpa–IPV) in healthy adults☆

2015 Vaccine
Show All
- Source
- Cite
- Save
Citations (6)
Model based estimates of long-term persistence of inactivated hepatitis A vaccine-induced antibodies in adults.

2014 Vaccine
Show All
- Source
- Cite
- Save
Citations (49)
Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study

2014 The Lancet
Show All
- Source
- Cite
- Save
Citations (154)
656Immunogenicity and Safety Evaluation of a New Syringe Presentation of Reduced Antigen Content Diphtheria-Tetanus-Acellular Pertussis Vaccine in Healthy Adolescents: Results from a Randomized Trial

2014 Open Forum Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (0)